Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Gastrointestinal Disorder Therapeutics Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Irritable Bowel Syndrome (IBS)
1.2.3 Chronic Constipation (CC)
1.2.4 Ulcerative Colitis (UC)
1.3 Market by Application
1.3.1 Global Gastrointestinal Disorder Therapeutics Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Gastrointestinal Disorder Therapeutics Market Perspective (2018-2033)
2.2 Gastrointestinal Disorder Therapeutics Growth Trends by Region
2.2.1 Global Gastrointestinal Disorder Therapeutics Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Gastrointestinal Disorder Therapeutics Historic Market Size by Region (2018-2023)
2.2.3 Gastrointestinal Disorder Therapeutics Forecasted Market Size by Region (2024-2033)
2.3 Gastrointestinal Disorder Therapeutics Market Dynamics
2.3.1 Gastrointestinal Disorder Therapeutics Industry Trends
2.3.2 Gastrointestinal Disorder Therapeutics Market Drivers
2.3.3 Gastrointestinal Disorder Therapeutics Market Challenges
2.3.4 Gastrointestinal Disorder Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Gastrointestinal Disorder Therapeutics Players by Revenue
3.1.1 Global Top Gastrointestinal Disorder Therapeutics Players by Revenue (2018-2023)
3.1.2 Global Gastrointestinal Disorder Therapeutics Revenue Market Share by Players (2018-2023)
3.2 Global Gastrointestinal Disorder Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Gastrointestinal Disorder Therapeutics Revenue
3.4 Global Gastrointestinal Disorder Therapeutics Market Concentration Ratio
3.4.1 Global Gastrointestinal Disorder Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Gastrointestinal Disorder Therapeutics Revenue in 2022
3.5 Gastrointestinal Disorder Therapeutics Key Players Head office and Area Served
3.6 Key Players Gastrointestinal Disorder Therapeutics Product Solution and Service
3.7 Date of Enter into Gastrointestinal Disorder Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Gastrointestinal Disorder Therapeutics Breakdown Data by Type
4.1 Global Gastrointestinal Disorder Therapeutics Historic Market Size by Type (2018-2023)
4.2 Global Gastrointestinal Disorder Therapeutics Forecasted Market Size by Type (2024-2033)
5 Gastrointestinal Disorder Therapeutics Breakdown Data by Application
5.1 Global Gastrointestinal Disorder Therapeutics Historic Market Size by Application (2018-2023)
5.2 Global Gastrointestinal Disorder Therapeutics Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Gastrointestinal Disorder Therapeutics Market Size (2018-2033)
6.2 North America Gastrointestinal Disorder Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Gastrointestinal Disorder Therapeutics Market Size by Country (2018-2023)
6.4 North America Gastrointestinal Disorder Therapeutics Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Gastrointestinal Disorder Therapeutics Market Size (2018-2033)
7.2 Europe Gastrointestinal Disorder Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Gastrointestinal Disorder Therapeutics Market Size by Country (2018-2023)
7.4 Europe Gastrointestinal Disorder Therapeutics Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Gastrointestinal Disorder Therapeutics Market Size (2018-2033)
8.2 Asia-Pacific Gastrointestinal Disorder Therapeutics Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Gastrointestinal Disorder Therapeutics Market Size by Region (2018-2023)
8.4 Asia-Pacific Gastrointestinal Disorder Therapeutics Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Gastrointestinal Disorder Therapeutics Market Size (2018-2033)
9.2 Latin America Gastrointestinal Disorder Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Gastrointestinal Disorder Therapeutics Market Size by Country (2018-2023)
9.4 Latin America Gastrointestinal Disorder Therapeutics Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Gastrointestinal Disorder Therapeutics Market Size (2018-2033)
10.2 Middle East & Africa Gastrointestinal Disorder Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Gastrointestinal Disorder Therapeutics Market Size by Country (2018-2023)
10.4 Middle East & Africa Gastrointestinal Disorder Therapeutics Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 AstraZeneca
11.1.1 AstraZeneca Company Detail
11.1.2 AstraZeneca Business Overview
11.1.3 AstraZeneca Gastrointestinal Disorder Therapeutics Introduction
11.1.4 AstraZeneca Revenue in Gastrointestinal Disorder Therapeutics Business (2018-2023)
11.1.5 AstraZeneca Recent Development
11.2 Takeda Pharmaceutical
11.2.1 Takeda Pharmaceutical Company Detail
11.2.2 Takeda Pharmaceutical Business Overview
11.2.3 Takeda Pharmaceutical Gastrointestinal Disorder Therapeutics Introduction
11.2.4 Takeda Pharmaceutical Revenue in Gastrointestinal Disorder Therapeutics Business (2018-2023)
11.2.5 Takeda Pharmaceutical Recent Development
11.3 Johnson & Johnson
11.3.1 Johnson & Johnson Company Detail
11.3.2 Johnson & Johnson Business Overview
11.3.3 Johnson & Johnson Gastrointestinal Disorder Therapeutics Introduction
11.3.4 Johnson & Johnson Revenue in Gastrointestinal Disorder Therapeutics Business (2018-2023)
11.3.5 Johnson & Johnson Recent Development
11.4 Eisai
11.4.1 Eisai Company Detail
11.4.2 Eisai Business Overview
11.4.3 Eisai Gastrointestinal Disorder Therapeutics Introduction
11.4.4 Eisai Revenue in Gastrointestinal Disorder Therapeutics Business (2018-2023)
11.4.5 Eisai Recent Development
11.5 Abbott Laboratories
11.5.1 Abbott Laboratories Company Detail
11.5.2 Abbott Laboratories Business Overview
11.5.3 Abbott Laboratories Gastrointestinal Disorder Therapeutics Introduction
11.5.4 Abbott Laboratories Revenue in Gastrointestinal Disorder Therapeutics Business (2018-2023)
11.5.5 Abbott Laboratories Recent Development
11.6 Salix Pharmaceuticals
11.6.1 Salix Pharmaceuticals Company Detail
11.6.2 Salix Pharmaceuticals Business Overview
11.6.3 Salix Pharmaceuticals Gastrointestinal Disorder Therapeutics Introduction
11.6.4 Salix Pharmaceuticals Revenue in Gastrointestinal Disorder Therapeutics Business (2018-2023)
11.6.5 Salix Pharmaceuticals Recent Development
11.7 Bausch Health
11.7.1 Bausch Health Company Detail
11.7.2 Bausch Health Business Overview
11.7.3 Bausch Health Gastrointestinal Disorder Therapeutics Introduction
11.7.4 Bausch Health Revenue in Gastrointestinal Disorder Therapeutics Business (2018-2023)
11.7.5 Bausch Health Recent Development
11.8 Allergan
11.8.1 Allergan Company Detail
11.8.2 Allergan Business Overview
11.8.3 Allergan Gastrointestinal Disorder Therapeutics Introduction
11.8.4 Allergan Revenue in Gastrointestinal Disorder Therapeutics Business (2018-2023)
11.8.5 Allergan Recent Development
11.9 Bayer
11.9.1 Bayer Company Detail
11.9.2 Bayer Business Overview
11.9.3 Bayer Gastrointestinal Disorder Therapeutics Introduction
11.9.4 Bayer Revenue in Gastrointestinal Disorder Therapeutics Business (2018-2023)
11.9.5 Bayer Recent Development
11.10 UCB
11.10.1 UCB Company Detail
11.10.2 UCB Business Overview
11.10.3 UCB Gastrointestinal Disorder Therapeutics Introduction
11.10.4 UCB Revenue in Gastrointestinal Disorder Therapeutics Business (2018-2023)
11.10.5 UCB Recent Development
11.11 AbbVie
11.11.1 AbbVie Company Detail
11.11.2 AbbVie Business Overview
11.11.3 AbbVie Gastrointestinal Disorder Therapeutics Introduction
11.11.4 AbbVie Revenue in Gastrointestinal Disorder Therapeutics Business (2018-2023)
11.11.5 AbbVie Recent Development
11.12 GlaxoSmithKline
11.12.1 GlaxoSmithKline Company Detail
11.12.2 GlaxoSmithKline Business Overview
11.12.3 GlaxoSmithKline Gastrointestinal Disorder Therapeutics Introduction
11.12.4 GlaxoSmithKline Revenue in Gastrointestinal Disorder Therapeutics Business (2018-2023)
11.12.5 GlaxoSmithKline Recent Development
11.13 Astellas Pharma
11.13.1 Astellas Pharma Company Detail
11.13.2 Astellas Pharma Business Overview
11.13.3 Astellas Pharma Gastrointestinal Disorder Therapeutics Introduction
11.13.4 Astellas Pharma Revenue in Gastrointestinal Disorder Therapeutics Business (2018-2023)
11.13.5 Astellas Pharma Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Gastrointestinal Disorder Therapeutics Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Irritable Bowel Syndrome (IBS)
Table 3. Key Players of Chronic Constipation (CC)
Table 4. Key Players of Ulcerative Colitis (UC)
Table 5. Global Gastrointestinal Disorder Therapeutics Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Gastrointestinal Disorder Therapeutics Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 7. Global Gastrointestinal Disorder Therapeutics Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global Gastrointestinal Disorder Therapeutics Market Share by Region (2018-2023)
Table 9. Global Gastrointestinal Disorder Therapeutics Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 10. Global Gastrointestinal Disorder Therapeutics Market Share by Region (2024-2033)
Table 11. Gastrointestinal Disorder Therapeutics Market Trends
Table 12. Gastrointestinal Disorder Therapeutics Market Drivers
Table 13. Gastrointestinal Disorder Therapeutics Market Challenges
Table 14. Gastrointestinal Disorder Therapeutics Market Restraints
Table 15. Global Gastrointestinal Disorder Therapeutics Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global Gastrointestinal Disorder Therapeutics Market Share by Players (2018-2023)
Table 17. Global Top Gastrointestinal Disorder Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gastrointestinal Disorder Therapeutics as of 2022)
Table 18. Ranking of Global Top Gastrointestinal Disorder Therapeutics Companies by Revenue (US$ Million) in 2022
Table 19. Global 5 Largest Players Market Share by Gastrointestinal Disorder Therapeutics Revenue (CR5 and HHI) & (2018-2023)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Gastrointestinal Disorder Therapeutics Product Solution and Service
Table 22. Date of Enter into Gastrointestinal Disorder Therapeutics Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Gastrointestinal Disorder Therapeutics Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global Gastrointestinal Disorder Therapeutics Revenue Market Share by Type (2018-2023)
Table 26. Global Gastrointestinal Disorder Therapeutics Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 27. Global Gastrointestinal Disorder Therapeutics Revenue Market Share by Type (2024-2033)
Table 28. Global Gastrointestinal Disorder Therapeutics Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global Gastrointestinal Disorder Therapeutics Revenue Market Share by Application (2018-2023)
Table 30. Global Gastrointestinal Disorder Therapeutics Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 31. Global Gastrointestinal Disorder Therapeutics Revenue Market Share by Application (2024-2033)
Table 32. North America Gastrointestinal Disorder Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 33. North America Gastrointestinal Disorder Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 34. North America Gastrointestinal Disorder Therapeutics Market Size by Country (2024-2033) & (US$ Million)
Table 35. Europe Gastrointestinal Disorder Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 36. Europe Gastrointestinal Disorder Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 37. Europe Gastrointestinal Disorder Therapeutics Market Size by Country (2024-2033) & (US$ Million)
Table 38. Asia-Pacific Gastrointestinal Disorder Therapeutics Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 39. Asia-Pacific Gastrointestinal Disorder Therapeutics Market Size by Region (2018-2023) & (US$ Million)
Table 40. Asia-Pacific Gastrointestinal Disorder Therapeutics Market Size by Region (2024-2033) & (US$ Million)
Table 41. Latin America Gastrointestinal Disorder Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 42. Latin America Gastrointestinal Disorder Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 43. Latin America Gastrointestinal Disorder Therapeutics Market Size by Country (2024-2033) & (US$ Million)
Table 44. Middle East & Africa Gastrointestinal Disorder Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 45. Middle East & Africa Gastrointestinal Disorder Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 46. Middle East & Africa Gastrointestinal Disorder Therapeutics Market Size by Country (2024-2033) & (US$ Million)
Table 47. AstraZeneca Company Detail
Table 48. AstraZeneca Business Overview
Table 49. AstraZeneca Gastrointestinal Disorder Therapeutics Product
Table 50. AstraZeneca Revenue in Gastrointestinal Disorder Therapeutics Business (2018-2023) & (US$ Million)
Table 51. AstraZeneca Recent Development
Table 52. Takeda Pharmaceutical Company Detail
Table 53. Takeda Pharmaceutical Business Overview
Table 54. Takeda Pharmaceutical Gastrointestinal Disorder Therapeutics Product
Table 55. Takeda Pharmaceutical Revenue in Gastrointestinal Disorder Therapeutics Business (2018-2023) & (US$ Million)
Table 56. Takeda Pharmaceutical Recent Development
Table 57. Johnson & Johnson Company Detail
Table 58. Johnson & Johnson Business Overview
Table 59. Johnson & Johnson Gastrointestinal Disorder Therapeutics Product
Table 60. Johnson & Johnson Revenue in Gastrointestinal Disorder Therapeutics Business (2018-2023) & (US$ Million)
Table 61. Johnson & Johnson Recent Development
Table 62. Eisai Company Detail
Table 63. Eisai Business Overview
Table 64. Eisai Gastrointestinal Disorder Therapeutics Product
Table 65. Eisai Revenue in Gastrointestinal Disorder Therapeutics Business (2018-2023) & (US$ Million)
Table 66. Eisai Recent Development
Table 67. Abbott Laboratories Company Detail
Table 68. Abbott Laboratories Business Overview
Table 69. Abbott Laboratories Gastrointestinal Disorder Therapeutics Product
Table 70. Abbott Laboratories Revenue in Gastrointestinal Disorder Therapeutics Business (2018-2023) & (US$ Million)
Table 71. Abbott Laboratories Recent Development
Table 72. Salix Pharmaceuticals Company Detail
Table 73. Salix Pharmaceuticals Business Overview
Table 74. Salix Pharmaceuticals Gastrointestinal Disorder Therapeutics Product
Table 75. Salix Pharmaceuticals Revenue in Gastrointestinal Disorder Therapeutics Business (2018-2023) & (US$ Million)
Table 76. Salix Pharmaceuticals Recent Development
Table 77. Bausch Health Company Detail
Table 78. Bausch Health Business Overview
Table 79. Bausch Health Gastrointestinal Disorder Therapeutics Product
Table 80. Bausch Health Revenue in Gastrointestinal Disorder Therapeutics Business (2018-2023) & (US$ Million)
Table 81. Bausch Health Recent Development
Table 82. Allergan Company Detail
Table 83. Allergan Business Overview
Table 84. Allergan Gastrointestinal Disorder Therapeutics Product
Table 85. Allergan Revenue in Gastrointestinal Disorder Therapeutics Business (2018-2023) & (US$ Million)
Table 86. Allergan Recent Development
Table 87. Bayer Company Detail
Table 88. Bayer Business Overview
Table 89. Bayer Gastrointestinal Disorder Therapeutics Product
Table 90. Bayer Revenue in Gastrointestinal Disorder Therapeutics Business (2018-2023) & (US$ Million)
Table 91. Bayer Recent Development
Table 92. UCB Company Detail
Table 93. UCB Business Overview
Table 94. UCB Gastrointestinal Disorder Therapeutics Product
Table 95. UCB Revenue in Gastrointestinal Disorder Therapeutics Business (2018-2023) & (US$ Million)
Table 96. UCB Recent Development
Table 97. AbbVie Company Detail
Table 98. AbbVie Business Overview
Table 99. AbbVie Gastrointestinal Disorder Therapeutics Product
Table 100. AbbVie Revenue in Gastrointestinal Disorder Therapeutics Business (2018-2023) & (US$ Million)
Table 101. AbbVie Recent Development
Table 102. GlaxoSmithKline Company Detail
Table 103. GlaxoSmithKline Business Overview
Table 104. GlaxoSmithKline Gastrointestinal Disorder Therapeutics Product
Table 105. GlaxoSmithKline Revenue in Gastrointestinal Disorder Therapeutics Business (2018-2023) & (US$ Million)
Table 106. GlaxoSmithKline Recent Development
Table 107. Astellas Pharma Company Detail
Table 108. Astellas Pharma Business Overview
Table 109. Astellas Pharma Gastrointestinal Disorder Therapeutics Product
Table 110. Astellas Pharma Revenue in Gastrointestinal Disorder Therapeutics Business (2018-2023) & (US$ Million)
Table 111. Astellas Pharma Recent Development
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Gastrointestinal Disorder Therapeutics Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Gastrointestinal Disorder Therapeutics Market Share by Type: 2022 VS 2033
Figure 3. Irritable Bowel Syndrome (IBS) Features
Figure 4. Chronic Constipation (CC) Features
Figure 5. Ulcerative Colitis (UC) Features
Figure 6. Global Gastrointestinal Disorder Therapeutics Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 7. Global Gastrointestinal Disorder Therapeutics Market Share by Application: 2022 VS 2033
Figure 8. Hospitals Case Studies
Figure 9. Clinics Case Studies
Figure 10. Others Case Studies
Figure 11. Gastrointestinal Disorder Therapeutics Report Years Considered
Figure 12. Global Gastrointestinal Disorder Therapeutics Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 13. Global Gastrointestinal Disorder Therapeutics Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 14. Global Gastrointestinal Disorder Therapeutics Market Share by Region: 2022 VS 2033
Figure 15. Global Gastrointestinal Disorder Therapeutics Market Share by Players in 2022
Figure 16. Global Top Gastrointestinal Disorder Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gastrointestinal Disorder Therapeutics as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Gastrointestinal Disorder Therapeutics Revenue in 2022
Figure 18. North America Gastrointestinal Disorder Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 19. North America Gastrointestinal Disorder Therapeutics Market Share by Country (2018-2033)
Figure 20. United States Gastrointestinal Disorder Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. Canada Gastrointestinal Disorder Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Europe Gastrointestinal Disorder Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Europe Gastrointestinal Disorder Therapeutics Market Share by Country (2018-2033)
Figure 24. Germany Gastrointestinal Disorder Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. France Gastrointestinal Disorder Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. U.K. Gastrointestinal Disorder Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Italy Gastrointestinal Disorder Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Russia Gastrointestinal Disorder Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Nordic Countries Gastrointestinal Disorder Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Asia-Pacific Gastrointestinal Disorder Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Asia-Pacific Gastrointestinal Disorder Therapeutics Market Share by Region (2018-2033)
Figure 32. China Gastrointestinal Disorder Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Japan Gastrointestinal Disorder Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. South Korea Gastrointestinal Disorder Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Southeast Asia Gastrointestinal Disorder Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. India Gastrointestinal Disorder Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Australia Gastrointestinal Disorder Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Latin America Gastrointestinal Disorder Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Latin America Gastrointestinal Disorder Therapeutics Market Share by Country (2018-2033)
Figure 40. Mexico Gastrointestinal Disorder Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Brazil Gastrointestinal Disorder Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Middle East & Africa Gastrointestinal Disorder Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Middle East & Africa Gastrointestinal Disorder Therapeutics Market Share by Country (2018-2033)
Figure 44. Turkey Gastrointestinal Disorder Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Saudi Arabia Gastrointestinal Disorder Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. AstraZeneca Revenue Growth Rate in Gastrointestinal Disorder Therapeutics Business (2018-2023)
Figure 47. Takeda Pharmaceutical Revenue Growth Rate in Gastrointestinal Disorder Therapeutics Business (2018-2023)
Figure 48. Johnson & Johnson Revenue Growth Rate in Gastrointestinal Disorder Therapeutics Business (2018-2023)
Figure 49. Eisai Revenue Growth Rate in Gastrointestinal Disorder Therapeutics Business (2018-2023)
Figure 50. Abbott Laboratories Revenue Growth Rate in Gastrointestinal Disorder Therapeutics Business (2018-2023)
Figure 51. Salix Pharmaceuticals Revenue Growth Rate in Gastrointestinal Disorder Therapeutics Business (2018-2023)
Figure 52. Bausch Health Revenue Growth Rate in Gastrointestinal Disorder Therapeutics Business (2018-2023)
Figure 53. Allergan Revenue Growth Rate in Gastrointestinal Disorder Therapeutics Business (2018-2023)
Figure 54. Bayer Revenue Growth Rate in Gastrointestinal Disorder Therapeutics Business (2018-2023)
Figure 55. UCB Revenue Growth Rate in Gastrointestinal Disorder Therapeutics Business (2018-2023)
Figure 56. AbbVie Revenue Growth Rate in Gastrointestinal Disorder Therapeutics Business (2018-2023)
Figure 57. GlaxoSmithKline Revenue Growth Rate in Gastrointestinal Disorder Therapeutics Business (2018-2023)
Figure 58. Astellas Pharma Revenue Growth Rate in Gastrointestinal Disorder Therapeutics Business (2018-2023)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed